4.7 Article

Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 216, 期 2, 页码 369-383

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20180722

关键词

-

资金

  1. National Institutes of Health [R35 HL135752, R01 HL128264, P01 HL131478, R01 HL111938, R01 HL131006]
  2. American Heart Association's Established Investigator Award
  3. Patricia and Scott Eston MGH Research Scholar Award
  4. Uehara Memorial Foundation
  5. Kanae Foundation for the Promotion of Medical Science
  6. Japan Society for the Promotion of Science (KAKENHI) [18K08048]
  7. Boehringer-Ingelheim Fonds MD fellowship
  8. American Heart Association postdoctoral fellowship
  9. Canadian Institutes of Health Research
  10. Banting Research Foundation
  11. Fondation pour la Recherche Medicale postdoctoral fellowship
  12. Grants-in-Aid for Scientific Research [18K08048] Funding Source: KAKEN

向作者/读者索取更多资源

Acquisition of self-reactive effector CD4(+) T cells is a major component of the autoimmune response that can occur during myocarditis, an inflammatory form of cardiomyopathy. Although the processes by which self-reactive T cells gain effector function have received considerable attention, how these T cells contribute to effector organ inflammation and damage is less clear. Here, we identified an IL-3-dependent amplification loop that exacerbates autoimmune inflammation. In experimental myocarditis, we show that effector organ-accumulating autoreactive IL-3(+) CD4(+) T cells stimulate IL-3R(+) tissue macrophages to produce monocyte-attracting chemokines. The newly recruited monocytes differentiate into antigen-presenting cells that stimulate local IL-3(+) CD4(+) T cell proliferation, thereby amplifying organ inflammation. Consequently, Il3(-/-) mice resist developing robust autoimmune inflammation and myocardial dysfunction, whereas therapeutic IL-3 targeting ameliorates disease. This study defines a mechanism that orchestrates inflammation in myocarditis, describes a previously unknown function for IL-3, and identifies IL-3 as a potential therapeutic target in patients with myocarditis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据